• Info
  • Insider Ownership

Insider Trading & Ownership of Andrew Arno

Location
San Francisco, CA
Summary
The estimated net worth of Andrew Arno is at least $571,338 dollars as of 30 Mar 2026. Andrew Arno is the Director of Oncocyte Corp and owns shares of Insight Molecular Diagnostics Inc. (IMDX) stock worth about $381.1K. Andrew Arno is the Director of 22nd Century Group, Inc. and owns shares of 22nd Century Group, Inc. (XXII) stock worth about $138.7K. Andrew Arno is the Director of SMITH MICRO SOFTWARE, INC. and owns shares of SMITH MICRO SOFTWARE, INC. (SMSI) stock worth about $51.5K.
Signature
/s/ Andrew Arno
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Andrew Arno and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • Andrew Arno has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $571,338.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Oncocyte Corp ($381,104).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Andrew Arno

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
IMDX Oncocyte Corp Director $381,104 01 Jul 2025
XXII 22nd Century Group, Inc. Director $138,738 10 Nov 2025
SMSI SMITH MICRO SOFTWARE, INC. Director $51,496 09 Mar 2026
VTAK Catheter Precision, Inc. Director 26 Mar 2026

Insider Transactions Reported by Andrew Arno:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.